Clostridioides difficile Toxin B Activates Group 3 Innate Lymphocytes.

Area of Science:

• Immunology
• Microbiology
• Gastroenterology

Background:

• Group 3 innate lymphocytes (ILC3s) are crucial immune cells in mucosal tissues, particularly the gut.
• ILC3s produce interleukin-22 (IL-22), a cytokine vital for epithelial protection during infection and inflammation.
• The precise mechanisms of ILC3 activation and IL-22 production in response to pathogens like Clostridioides difficile remain unclear.

Purpose of the Study:

• To elucidate the novel mechanisms of ILC3 activation by Clostridioides difficile.
• To identify how ILC3s sense infection and initiate an immune response through IL-22 production.

Main Methods:

• Investigated the direct effects of Clostridioides difficile Toxin B (TcdB) on ILC3s.
• Utilized pharmacological inhibition of small GTPases, specifically Cdc42.
• Performed gene expression analysis to identify modulated inflammatory pathways.

Main Results:

• Clostridioides difficile Toxin B directly induced IL-22 production in ILC3s.
• TcdB's glucosyltransferase activity, which inhibits small GTPases, was essential for IL-22 induction.
• Inhibiting Cdc42 enhanced IL-22 production, identifying Cdc42 as a negative regulator of ILC3 activation.
• TcdB treatment altered the expression of inflammation-related genes in ILC3s.

Conclusions:

• Clostridioides difficile toxin-mediated inhibition of Cdc42 is a novel mechanism for activating ILC3s.
• This pathway highlights how ILC3s are recruited into the immune response against C. difficile.
• Findings provide critical insights into the innate immune defense against gut pathogens.